[1]
Daniela C. Andrade et al. 2023. Insulin-like growth factor-1 short-period therapy improves Non-Alcoholic Fatty Liver Disease (NAFLD) in obese mice. Brazilian Journal of Health and Biomedical Sciences. 22, 2 (Dec. 2023), 81–90. DOI:https://doi.org/10.12957/bjhbs.2023.79959.